72F fusion protein

WikiDoc Resources for 72F fusion protein
Articles
Most recent articles on 72F fusion protein Most cited articles on 72F fusion protein Review articles on 72F fusion protein Articles on 72F fusion protein in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on 72F fusion protein Images of 72F fusion protein Photos of 72F fusion protein Podcasts & MP3s on 72F fusion protein Videos on 72F fusion protein
Evidence Based Medicine
Cochrane Collaboration on 72F fusion protein Bandolier on 72F fusion protein TRIP on 72F fusion protein
Clinical Trials
Ongoing Trials on 72F fusion protein at Clinical Trials.gov Trial results on 72F fusion protein Clinical Trials on 72F fusion protein at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on 72F fusion protein NICE Guidance on 72F fusion protein NHS PRODIGY Guidance FDA on 72F fusion protein CDC on 72F fusion protein
Books
Books on 72F fusion protein
News
72F fusion protein in the news Be alerted to news on 72F fusion protein News trends on 72F fusion protein
Commentary
Blogs on 72F fusion protein
Definitions
Definitions of 72F fusion protein
Patient Resources / Community
Patient resources on 72F fusion protein Discussion groups on 72F fusion protein Patient Handouts on 72F fusion protein Directions to Hospitals Treating 72F fusion protein Risk calculators and risk factors for 72F fusion protein
Healthcare Provider Resources
Symptoms of 72F fusion protein Causes & Risk Factors for 72F fusion protein Diagnostic studies for 72F fusion protein Treatment of 72F fusion protein
Continuing Medical Education (CME)
CME Programs on 72F fusion protein
International
72F fusion protein en Espanol 72F fusion protein en Francais
Business
72F fusion protein in the Marketplace Patents on 72F fusion protein
Experimental / Informatics
List of terms related to 72F fusion protein

Overview

72F fusion protein is a candidate tuberculosis vaccine created by SSI. The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.Kaufmann SHE, McMichael AJ (2005). "Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis". Nature Med. 11 (4 suppl): S33&ndash, S44. doi:10.1038/nm1221. PMID 15812488. Retrieved 2006-04-30.

Related Chapters

• Fusion protein

References

Template:WikiDoc Sources